Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lucky G Ngwira"'
Autor:
Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N Chifamba, Titus H Divala, Andres G Lescano, Mohammed Majam, Danjuma Mbo, Auliya A Suwantika, Marco A Tovar, Pragya Yadav, Obinna Ekwunife, Collin Mangenah, Lucky G Ngwira, Elizabeth L Corbett, Mark Jit, Anna Vassall
Publikováno v:
PLoS Medicine, Vol 21, Iss 7, p e1004429 (2024)
BackgroundRapid diagnostic tests (RDTs) for coronavirus disease (COVID) are used in low- and middle-income countries (LMICs) to inform treatment decisions. However, to date, it is unclear when this use is cost-effective. Existing analyses are limited
Externí odkaz:
https://doaj.org/article/bba47f2a0698436eb52870a89f7c44bb
Autor:
Lucky G Ngwira, Bhawana Sharma, Kabita Bade Shrestha, Sushil Dahal, Reshma Tuladhar, Gerald Manthalu, Ben Chilima, Allone Ganizani, Jonathan Rigby, Oscar Kanjerwa, Kayla Barnes, Catherine Anscombe, Joseph Mfutso-Bengo, Nicholas Feasey, Mercy Mvundura
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 12, p e0001377 (2022)
Environmental surveillance of rivers and wastewater for SARS-CoV-2 detection has been explored as an innovative way to surveil the pandemic. This study estimated the economic costs of conducting wastewater-based environmental surveillance for SARS-Co
Externí odkaz:
https://doaj.org/article/a646c7319e174e37b28401cf5f9afa2d
Autor:
Andrea M Rehman, Victoria Simms, Grace McHugh, Hilda Mujuru, Lucky G Ngwira, Robina Semphere, Brewster Moyo, Tsitsi Bandason, Jon O Odland, Rashida A Ferrand
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0269229 (2022)
BackgroundManagement of co-morbidities among persons living with HIV is an emerging priority, which may require additional medication over and above life-long antiretroviral therapy (ART). We explored factors associated with adherence to the trial dr
Externí odkaz:
https://doaj.org/article/b58dc8c80ebe4f8586e9886f417a93c9
Autor:
Amy Price, Grace McHugh, Victoria Simms, Robina Semphere, Lucky G Ngwira, Tsitsi Bandason, Hilda Mujuru, Jon O Odland, Rashida A Ferrand, Andrea M Rehman
Publikováno v:
EClinicalMedicine, Vol 42, Iss , Pp 101195- (2021)
Background: In the BREATHE trial weekly azithromycin decreased the rate of acute respiratory exacerbations (AREs) compared to placebo among children and adolescents with HIV-associated chronic lung disease (CLD) taking antiretroviral therapy (ART). T
Externí odkaz:
https://doaj.org/article/d03ae235e3c244d9a0cdbd7a1abb0876
Autor:
Christi Jackson, Andrea M. Rehman, Grace McHugh, Carmen Gonzalez-Martinez, Lucky G. Ngwira, Tsitsi Bandason, Hilda Mujuru, Jon O. Odland, Elizabeth L. Corbett, Rashida A. Ferrand, Victoria Simms
Publikováno v:
BMC Pediatrics, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background We investigated risk factors for sustained virological non-suppression (viral load ≥ 1000 copies/ml on two tests 48 weeks apart) among children and adolescents accessing HIV care in public sector clinics in Harare, Zimbabwe and
Externí odkaz:
https://doaj.org/article/1e889899aaec45e583d2f95cdc12e7c8
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
Autor:
Regina E. Abotsi, Mark P. Nicol, Grace McHugh, Victoria Simms, Andrea M. Rehman, Charmaine Barthus, Lucky G. Ngwira, Brenda Kwambana-Adams, Robert S. Heyderman, Jon Ø. Odland, Rashida A. Ferrand, Felix S. Dube
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2021)
Selection for resistance to azithromycin (AZM) and other antibiotics such as tetracyclines and lincosamides remains a concern with long-term AZM use for treatment of chronic lung diseases (CLD). We investigated the impact of 48 weeks of AZM on the ca
Externí odkaz:
https://doaj.org/article/93642902441a46e8ada69346547adadd
Autor:
Regina E. Abotsi, Felix S. Dube, Andrea M. Rehman, Shantelle Claassen-Weitz, Yao Xia, Victoria Simms, Kilaza S. Mwaikono, Sugnet Gardner-Lubbe, Grace McHugh, Lucky G. Ngwira, Brenda Kwambana-Adams, Robert S Heyderman, Jon Ø Odland, Rashida A Ferrand, Mark P. Nicol
Background Long-term azithromycin (AZM) treatment reduces the frequency of acute respiratory exacerbation in children and adolescents with HIV-associated chronic lung disease (HCLD). However, the impact of this treatment on the respiratory bacteriome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c3d3ba054859ecef003fc86bf3ec6ed
https://doi.org/10.21203/rs.3.rs-1386887/v1
https://doi.org/10.21203/rs.3.rs-1386887/v1
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
Autor:
Andrea M. Rehman, Rashida A. Ferrand, Lucky G. Ngwira, Victoria Simms, Mark P. Nicol, Charmaine Barthus, Brenda Kwambana-Adams, Robert S. Heyderman, Regina E. Abotsi, Felix S. Dube, Jon Øyvind Odland, Grace McHugh
Selection for resistance to azithromycin (AZM) and other antibiotics such as tetracyclines and lincosamides remains a concern with long-term AZM use for treatment of chronic lung diseases (CLD). We investigated the impact of 48 weeks of AZM on the ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3661f45cd4b81075ac2054fbe19ae69f
https://archive.lstmed.ac.uk/20097/1/PMC8819245.pdf
https://archive.lstmed.ac.uk/20097/1/PMC8819245.pdf
Autor:
Rashida A. Ferrand, Lucky G. Ngwira, Tore Jarl Gutteberg, Louis-Marie Yindom, Evgeniya Sovershaeva, Grace McHugh, Andrea M. Rehman, Sarah Rowland-Jones, Victoria Simms, Dan Hameiri-Bowen, Trond Flægstad, Tsitsi Bandason
Publikováno v:
AIDS
ObjectiveHIV-associated chronic lung disease (HCLD) is a common comorbidity in children and adolescents in sub-Saharan Africa (SSA). The pathogenesis of HCLD is unclear and may be driven by underlying dysregulated systemic immune activation and infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::080a0956e75a5ad37cd312ced6b96f63
https://pubmed.ncbi.nlm.nih.gov/34074817
https://pubmed.ncbi.nlm.nih.gov/34074817
Autor:
Rashida A. Ferrand, Brewster Moyo, Victoria Simms, Andrea M. Rehman, Slindile Mbhele, Felix S. Dube, Mark P. Nicol, Beauty Makamure, Jon Øyvind Odland, Justin Mayini, Regina E. Abotsi, Grace McHugh, Hilda Mujuru, Lucky G. Ngwira, Charmaine Barthus
Publikováno v:
BMC Infectious Diseases
Article number: 216
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-17 (2021)
Article number: 216
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-17 (2021)
Background HIV-associated chronic lung disease (CLD) is common among children living with HIV (CLWH) in sub-Saharan Africa, including those on antiretroviral therapy (ART). However, the pathogenesis of CLD and its possible association with microbial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3360f2bc228db504afaaa12138eea8a6
https://doi.org/10.1186/s12879-021-05904-3
https://doi.org/10.1186/s12879-021-05904-3